SCHEMBL21667274

SCHEMBL21667274

CC(C)(C)n1c(=O)cc(NCc2ccccc2)[nH]c1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ TP53 P04637 1/20 0.51
▸ CDC25B P30305 1/20 0.48
▸ KMT2A Q03164 3/20 0.47
▸ MEN1 O00255 2/20 0.45
▸ PIK3CB P42338 2/20 0.43
▸ PIK3CA P42336 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ RECQL P46063 1/20 0.41
▸ GPR84 Q9NQS5 1/20 0.40
▸ FABP4 P15090 1/20 0.39
▸ GLA P06280 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22639826 0.81 SMN1; SMN2 (0.74) SMN1; SMN2TP53CDC25BKMT2AMEN1
SCHEMBL21667215 0.80 SMN1; SMN2 (0.53) SMN1; SMN2TP53CDC25BKMT2AMEN1
SCHEMBL21667187 0.78 SMN1; SMN2 (0.54) SMN1; SMN2TP53CDC25BKMT2AMEN1
SCHEMBL20716038 0.78 CYP3A4 (0.61) SMN1; SMN2TP53CDC25BKMT2AMEN1
SCHEMBL21667343 0.77 MEN1 (0.61) SMN1; SMN2TP53CDC25BKMT2AMEN1
SCHEMBL21667214 0.77 SMN1; SMN2 (0.47) SMN1; SMN2TP53CDC25BKMT2AMEN1
SCHEMBL21667210 0.76 SMN1; SMN2 (0.47) SMN1; SMN2TP53CDC25BKMT2AMEN1
SCHEMBL21667361 0.76 SMN1; SMN2 (0.49) SMN1; SMN2TP53CDC25BKMT2AMEN1
SCHEMBL21667373 0.76 SMN1; SMN2 (0.46) SMN1; SMN2TP53CDC25BKMT2AMEN1
SCHEMBL21667366 0.75 SMN1; SMN2 (0.48) SMN1; SMN2TP53CDC25BKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3702352-A1 PYRIMIDINEDIONE COMPOUND AGAINST CARDIAC CONDITIONS Myokardia, Inc. (US) 2020-09-02 — — EP disclosed
EP-3010910-B1 PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS MYOKARDIA INC (US) 2020-02-05 — — EP disclosed
Send feedback